Cambridge biotech cuts most staffers after merger falls apart


A Cambridge biotech is laying off most of its staff in the wake of a failed merger agreement.

Previous RTP gene therapy firm adds $150M in funding
Next Audiobook publishing company on Spotify, Audible joins H.I.G. Capital's portfolio